I hope everyone is having a good summer so far. As we move through 2025, there are two important developments I want to share with you that will shape pharmacy practice in BC for the foreseeable future.
CPBC is launching CIRCL (Continuous Improvement, Reporting, Collaborating, and Learning), a comprehensive medication incident reporting program designed to enhance medication safety through structured reporting, analysis, and learning from medication incidents in pharmacies across British Columbia.
CPBC's 2024/2025 annual report and audited financial statements are now available.
This year’s report highlights meaningful progress in strengthening pharmacy regulation and upholding our commitment to public protection.
On July 17, 2025, the Province announced that tirzepatide and dulaglutide, more commonly referred to by their brand names Mounjaro and Trulicity, will now be included in the "Limits on Sale" regulation under the Pharmacy Operations and Drug Scheduling Act (PODSA) to preserve supply of these diabetes drugs in British Columbia.
The Ministry of Health has confirmed that the Health Professions Act (HPA) will be repealed on April 1, 2026 and replaced by the Health Professions and Occupations Act (HPOA).
There has been a significant increase in measles cases across multiple health authorities in British Columbia. The risk of contracting measles and having severe complications is particularly high among unvaccinated populations.
The College of Pharmacists of British Columbia (CPBC) is seeking your feedback on proposed amendments to the Health Professions Act (HPA) Bylaws.
The proposed amendments are open for public comment for a 14-day period closing on July 17, 2025.